Provocation of myocardial ischemic events during initiation of vasodilator therapy for severe chronic heart failure: Clinical and hemodynamic evaluation of 52 consecutive patients with ischemie cardiomyopathy
- 30 November 1981
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 48 (5) , 939-946
- https://doi.org/10.1016/0002-9149(81)90362-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.Circulation, 1981
- Importance of Left Ventricular Chamber Size in Determining the Response to Hydralazine in Severe Chronic Heart FailureNew England Journal of Medicine, 1980
- Rest and exercise hemodynamic effects of oral hydralazine in patients with coronary artery disease and left ventricular dysfunction.Circulation, 1980
- Rebound Hemodynamic Events after the Abrupt Withdrawal of Nitroprusside in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1979
- Oral hydralazine therapy for chronic refractory heart failure.Circulation, 1976
- Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction.Circulation, 1976
- Hemodynamic and metabolic effects of sodium nitroprusside on the performance and metabolism of regional ischemic myocardium;.Circulation, 1975
- Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.Circulation, 1975
- Nonatheromatous Ischemic Heart Disease following Withdrawal from Chronic Industrial Nitroglycerin ExposureCirculation, 1972
- Observations on Angina Pectoris during Drug Treatment of HypertensionCirculation, 1956